China Stops Sales Of OTC Pediatric Drugs Containing Amantadine
This article was originally published in PharmAsia News
China’s State FDA has recently forbidden the use of three top-selling OTC pediatric compounds containing amantadine for infants under the age of 1 for safety and efficacy reasons.
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma